Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.

Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY.

Br J Cancer. 2006 Jun 19;94(12):1823-32.

3.

Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.

Hansen S, Sørensen FB, Vach W, Grabau DA, Bak M, Rose C.

Histopathology. 2004 May;44(5):428-36.

PMID:
15139990
4.

Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis.

Cheng SH, Liu JM, Liu QY, Luo DY, Liao BH, Li H, Wang KJ.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5855-63. eCollection 2014. Review.

5.

[The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer].

Saji S, Toi M, Tominaga T.

Nihon Geka Gakkai Zasshi. 1996 May;97(5):368-74. Review. Japanese.

PMID:
8709939
6.
7.

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F.

J Clin Oncol. 1994 Mar;12(3):454-66.

PMID:
7509851
8.

Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.

Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM.

Histol Histopathol. 2009 Aug;24(8):1049-59. doi: 10.14670/HH-24.1049.

PMID:
19554512
9.

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis.

Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP.

Br J Cancer. 2002 Sep 23;87(7):694-701.

10.

Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance.

Krishna Priya S, Kumar K, Hiran KR, Bindhu MR, Nagare RP, Vijaykumar DK, Ganesan TS.

Int J Clin Oncol. 2017 Feb;22(1):107-117. doi: 10.1007/s10147-016-1033-6. Epub 2016 Aug 27.

PMID:
27567920
11.
12.

Microvessel Density (MVD) in Locally Advanced Breast Cancer

Krishnapriya S, Malipatil B, Surekha S, Sundersingh S, Sridevi V, Ananthi B, Selvaluxmy G, Ganesan TS.

Asian Pac J Cancer Prev. 2019 May 25;20(5):1537-1545.

13.

Microvessel density as a prognostic factor in ovarian cancer: a systematic review and meta-analysis.

He L, Wang Q, Zhao X.

Asian Pac J Cancer Prev. 2015;16(3):869-74. Review.

14.

Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients.

Ludovini V, Sidoni A, Pistola L, Bellezza G, De Angelis V, Gori S, Mosconi AM, Bisagni G, Cherubini R, Bian AR, Rodinò C, Sabbatini R, Mazzocchi B, Bucciarelli E, Tonato M, Colozza M.

Breast Cancer Res Treat. 2003 Sep;81(2):159-68.

PMID:
14572158
15.

Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.

Lee N, Lee H, Moon SY, Sohn JY, Hwang SM, Yoon OJ, Youn HS, Eom HS, Kong SY.

Ann Lab Med. 2015 Nov;35(6):563-9. doi: 10.3343/alm.2015.35.6.563.

16.

Association of angiogenesis in lymph node metastases with outcome of breast cancer.

Guidi AJ, Berry DA, Broadwater G, Perloff M, Norton L, Barcos MP, Hayes DF.

J Natl Cancer Inst. 2000 Mar 15;92(6):486-92.

PMID:
10716967
17.

Prognostic value of microvessel density in invasive ductal carcinoma of the breast.

Tsutsui S, Kume M, Era S.

Breast Cancer. 2003;10(4):312-9.

PMID:
14634509
18.

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.

Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY, Peters WA, Stock RJ, Fruehauf JP.

Gynecol Oncol. 2009 Mar;112(3):583-9. doi: 10.1016/j.ygyno.2008.11.013. Epub 2008 Dec 24.

19.

Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.

Miyata Y, Mitsunari K, Asai A, Takehara K, Mochizuki Y, Sakai H.

Prostate. 2015 Jan;75(1):84-91. doi: 10.1002/pros.22894. Epub 2014 Oct 13.

20.

Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.

Rubatt JM, Darcy KM, Hutson A, Bean SM, Havrilesky LJ, Grace LA, Berchuck A, Secord AA.

Gynecol Oncol. 2009 Mar;112(3):469-74. doi: 10.1016/j.ygyno.2008.11.030. Epub 2009 Jan 9.

PMID:
19135712

Supplemental Content

Support Center